PALO ALTO, Calif., Oct. 11 /PRNewswire/ — Arable Corporation
(www.arablecorp.com) has
announced the launch of Arable Perform to bring unique CTMS
technologies to the clinical trial industry. Whereas
traditional CTMS systems have been costly and require months to
implement, Perform brings CTMS and EDC capabilities without the
traditionally high start-up costs.
The Arable Perform platform allows Sponsors or CROs to manage
the planning and implementation of multiple trials simultaneously.
Perform also provides large Sites with the ability to manage
their service delivery to multiple CROs or Sponsors. With
Perform’s proprietary dashboard, stakeholders and managers are able
to view real-time status of trials down to the site or subject
visit.
“Our new Arable Perform platform allows us to offer our clients
immediate access to clinical trial software with the shortest “Go
Live” time in the industry and at a reasonable cost,” stated Ary
Sarkar, CEO of Arable Corporation. “At Arable, we combine our
knowledge of the clinical trial space with our technology
partnerships to offer our clients a range of services from trial
planning and implementation through regulatory submittal.”
Arable brings a suite of services to offer the pharmaceutical
and biotech industries. With the addition of the Perform
platform, Arable introduces CTMS and EDC software to complement
their existing partnerships with GlobalSubmit and Quest Life
Sciences.
Arable is announcing a 30 day free trial of their Perform
platform to highlight the benefits to clinical organizations.
With the economic recovery continuing to affect pharma and
biotech R & D budgets, Arable believes that the Perform
software will save clinical organizations money and increase time
to market. Terms and conditions apply to the free offer.
Arable Corporation combines the right technology with our proven
CRO servic
‘/>”/>
